Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Nu-Med Plus Inc./ PRE 14A

SEC Filing · PRE 14A

Nu-Med Plus Inc.

NUMDOTCEQUITYCurrent

SEC Filing

Filed Nov 2, 2026Accepted Oct 30, 2026, 6:20 PM EDTCIK 1543637Accession 0001575872-26-000753
View company →Permanent SEC source ↗
Share

Company context

Nu-Med Plus, Inc. is a Utah company whose shares are quoted on the OTCQB Venture Market. Following the acquisition of Avid Gold Ltd, Nu-Med Plus, Inc. will diversify its operations by expanding into gold exploration and development, in addition to its existing medical device business.

Current securities

NUMDOTC · EQUITY · Current

Recent company filings

  1. Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Shareholder Director Nominations · Other EventsNov 2, 2026
  2. Entry into a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesOct 20, 2026
  3. SCHEDULE 13D - filed by TEJADA FRED regarding Nu-Med Plus, Inc.Aug 25, 2026
  4. Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Unregistered Sales of Equity SecuritiesAug 25, 2026
  5. 10-Q filingAug 14, 2026

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.